Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases-Reference-Cited by-同舟云学术

Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases

Published:2018-02-16 Issue:2 Volume:50 Page:95-108
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Navarro-Mabarak Cynthia¹,Camacho-Carranza Rafael¹,Espinosa-Aguirre Jesús Javier¹

Affiliation:

1. Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México

Funder

CONACYT

UNAM

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2018.1439502

Reference111 articles.

1. Lanosterol 14-Demethylase Activity Expressed in Rat Brain Microsomes

2. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach

3. Regulation of expression of cytochrome P-450 2D mRNA in rat brain with steroid hormones

4. Polyunsaturated fatty acids and their metabolites in brain function and disease

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced neuroprotective effect of verapamil-loaded hyaluronic acid modified carbon quantum dots in an in-vitro model of amyloid-induced Alzheimer's disease;International Journal of Biological Macromolecules;2024-08

2. Exploring the Regulation of Cytochrome P450 in SH-SY5Y Cells: Implications for the Onset of Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-07-06

3. Control of metalloenzyme activity using photopharmacophores;Coordination Chemistry Reviews;2024-01

4. Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies;Molecular Neurodegeneration;2023-11-10

5. Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1;Acta Pharmaceutica Sinica B;2023-09